Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

ClinicalTrials.gov ID: NCT03294538

Public ClinicalTrials.gov record NCT03294538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Cream USP, 0.01% (Teva Pharmaceuticals, USA) to Estrace® Estradiol Vaginal Cream, USP, 0.01% (Warner Chilcott) in the Treatment of Atrophic Vaginitis

Study identification

NCT ID
NCT03294538
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actavis Inc.
Industry
Enrollment
663 participants

Conditions and interventions

Interventions

  • Generic Estradiol Vaginal Cream USP, 0.01% Drug
  • Estrace® Vaginal Cream USP, 0.01% Drug
  • Vehicle Vaginal Cream Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2016
Primary completion
Feb 14, 2017
Completion
Feb 14, 2017
Last update posted
Dec 25, 2019

2016 – 2017

United States locations

U.S. sites
44
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Site Number 44 Tucson Arizona 85710
Site Number 17 Tucson Arizona 85712
Site Number 31 La Mesa California 91942
Site Number 11 Sacramento California 95821
Site Number 05 San Diego California 91208
Site Number 15 San Diego California 92111
Site Number 25 Colorado Springs Colorado 80923
Site Number 01 Denver Colorado 80209
Site Number 14 Denver Colorado 80220
Site Number 18 New London Connecticut 06320
Site Number 06 Jupiter Florida 33458
Site Number 13 Lake Worth Florida 33461
Site Number 27 Miami Florida 33015
Site Number 40 Miami Florida 33130
Site Number 20 Miami Florida 33136
Site Number 39 Miami Florida 33144
Site Number 38 Miami Florida 33186
Site Number 30 Miami Lakes Florida 33014
Site Number 08 New Port Richey Florida 34652
Site Number 03 Ormond Beach Florida 32174
Site Number 45 Port Saint Lucie Florida 34952
Site Number 10 Sarasota Florida 34239
Site Number 19 St. Petersburg Florida 33709
Site Number 02 West Palm Beach Florida 33409
Site Number 29 Roswell Georgia 30075
Site Number 22 Savannah Georgia 31406
Site Number 21 Wichita Kansas 67226
Site Number 33 Metairie Louisiana 70001
Site Number 16 Kalamazoo Michigan 49009
Site Number 34 Saginaw Michigan 48604
Site Number 35 Lincoln Nebraska 68510
Site Number 12 Lawrenceville New Jersey 08648
Site Number 26 Plainsboro New Jersey 08536
Site Number 36 Raleigh North Carolina 27607
Site Number 04 Winston-Salem North Carolina 27103
Site Number 37 Winston-Salem North Carolina 27103
Site Number 07 Columbus Ohio 43213
Site Number 24 Englewood Ohio 45322
Site Number 28 West Chester Ohio 45069
Site Number 23 Bluffton South Carolina 29910
Site Number 41 Mt. Pleasant South Carolina 29464
Site Number 43 Myrtle Beach South Carolina 29572
Site Number 32 Dallas Texas 75230
Site Number 09 Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03294538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03294538 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →